An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at a young age

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can delay the disease.

A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who are yet to show symptoms. The just-published results from a clinical trial on an experimental drug targeting amyloid plaque buildup suggest the treatment can indeed put the brakes on cognitive decline,